We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$859M
AUM Growth
-$429M
Cap. Flow
-$442M
Cap. Flow %
-51.43%
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$5.95M
2
MRVL icon
Marvell Technology
MRVL
+$4M
3
AAPL icon
Apple
AAPL
+$3.97M
4
DIS icon
Walt Disney
DIS
+$3.95M
5
ROL icon
Rollins
ROL
+$3.82M

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.11M
2
ICE icon
Intercontinental Exchange
ICE
+$6.91M
3
XRAY icon
Dentsply Sirona
XRAY
+$6.81M
4
CSCO icon
Cisco
CSCO
+$6.77M
5
QRVO icon
Qorvo
QRVO
+$6.72M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 16.59%
3 Industrials 13.62%
4 Financials 13.07%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RBLX icon
1301
Roblox
RBLX
$26.6B
– –
-35,167
Closed -$1.26M
RCKT icon
1302
Rocket Pharmaceuticals
RCKT
$364M
– –
-34,397
Closed -$549K
RCUS icon
1303
Arcus Biosciences
RCUS
$3.54B
– –
-28,451
Closed -$744K
RDW icon
1304
Redwire
RDW
$2.46B
– –
-23,223
Closed -$55K
RGP icon
1305
Resources Connection
RGP
$155M
– –
-14,450
Closed -$261K
RKT icon
1306
Rocket Companies
RKT
$40.2B
– –
-37,787
Closed -$239K
RNAC icon
1307
Cartesian Therapeutics
RNAC
$232M
– –
-682
Closed -$34K
RNG icon
1308
RingCentral
RNG
$4.98B
– –
-25,784
Closed -$1.03M
RNR icon
1309
RenaissanceRe
RNR
$13.3B
– –
-3,427
Closed -$481K
RNST icon
1310
Renasant Corp
RNST
$4.05B
– –
-25,072
Closed -$784K
RNW icon
1311
ReNew
RNW
$2.29B
– –
-62,093
Closed -$374K
ROP icon
1312
Roper Technologies
ROP
$38.3B
– –
-9,869
Closed -$3.55M
RPRX icon
1313
Royalty Pharma
RPRX
$25.6B
– –
-22,149
Closed -$890K
RTX icon
1314
RTX Corp
RTX
$292B
– –
-25,406
Closed -$2.08M
RVLV icon
1315
Revolve Group
RVLV
$1.88B
– –
-113,491
Closed -$2.46M
RXRX icon
1316
Recursion Pharmaceuticals
RXRX
$1.75B
– –
-48,971
Closed -$521K
SABR icon
1317
Sabre
SABR
$822M
– –
-29,269
Closed -$151K
SAH icon
1318
Sonic Automotive
SAH
$2.72B
– –
-5,590
Closed -$242K
SAM icon
1319
Boston Beer
SAM
$1.93B
– –
-1,347
Closed -$436K
SANA icon
1320
Sana Biotechnology
SANA
$910M
– –
-48,411
Closed -$290K
FLNA
1321
Filana Therapeutics
FLNA
$48.3M
– –
-4,911
Closed -$205K
SBCF icon
1322
Seacoast Banking Corp of Florida
SBCF
$3.43B
– –
-21,843
Closed -$660K
SEE
1323
DELISTED
Sealed Air
SEE
– –
-13,907
Closed -$619K
SFL icon
1324
SFL Corp
SFL
$1.61B
– –
-98,215
Closed -$895K
SFNC icon
1325
Simmons First National
SFNC
$3.49B
– –
-13,844
Closed -$302K
51 52
53
54 55

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Occudo Quantitative Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.

  • Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
  • Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
  • Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
  • Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
  • Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
  • Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.